Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol for central neuropathic pain in multiple sclerosis
NCT00959218Phase 3Completed
- Sponsor
- Bionorica
- Start
- Jun 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dronabinol in central neuropathic pain (CNP), sponsored by Bionorica. Started Jun 2007; status: completed.
02
Drugs
dronabinol
03
Conditions
central neuropathic pain (CNP)
Beyond the preview
Go deeper on NCT00959218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00959218.